Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marina Ikic Matijasevic"'
Autor:
Darja Flegar, Maša Filipović, Alan Šućur, Antonio Markotić, Nina Lukač, Dino Šisl, Marina Ikić Matijašević, Zrinka Jajić, Tomislav Kelava, Vedran Katavić, Nataša Kovačić, Danka Grčević
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Detailed characterization of medullary and extramedullary reservoirs of osteoclast progenitors (OCPs) is required to understand the pathophysiology of increased periarticular and systemic bone resorption in arthritis. In this study, we focused on ide
Externí odkaz:
https://doaj.org/article/19b1ea8888ac4196b38ea6e603c61165
Autor:
Alan Sucur, Zrinka Jajic, Marinko Artukovic, Marina Ikic Matijasevic, Branimir Anic, Darja Flegar, Antonio Markotic, Tomislav Kelava, Sanja Ivcevic, Natasa Kovacic, Vedran Katavic, Danka Grcevic
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-16 (2017)
Abstract Background The peripheral blood (PB) monocyte pool contains osteoclast progenitors (OCPs), which contribute to osteoresorption in inflammatory arthritides and are influenced by the cytokine and chemokine milieu. We aimed to define the import
Externí odkaz:
https://doaj.org/article/4b0b6240c79d424dbf4e7e9621375454
Autor:
Marija Kurtov, Paula Kilić, Lucija Ikić, Karlo Kurtov, Gordan Dorčić, Marko Vodanović, Marinko Artuković, Marina Ikić Matijašević
Publikováno v:
Medicina, Vol 59, Iss 10, p 1784 (2023)
Fluoroquinolones are a commonly prescribed class of antibiotics due to their broad spectrum of antimicrobial activity, favorable pharmacokinetic properties, ability to switch from parenteral to oral administration, and global availability. After beta
Externí odkaz:
https://doaj.org/article/e68f433c9c3447459c6b46028cf1af92
Autor:
Paula Kilić, Lucija Ikić, Miroslav Mayer, Marinko Artuković, Ksenija Maštrović Radončić, Marina Ikić Matijašević
Publikováno v:
Medicina, Vol 59, Iss 9, p 1517 (2023)
Background: Rheumatoid arthritis (RA) is a chronic systemic autoimmune and inflammatory disease. Conventional synthetic and biologic disease-modifying antirheumatic drugs (DMARDs), Janus kinase inhibitors, and rituximab are used to treat the disease.
Externí odkaz:
https://doaj.org/article/d3984f43334e43d9a918857f8c919737
Publikováno v:
Acta Clinica Croatica, Vol 61., Iss Supplement 1, Pp 88-92 (2022)
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, also known as drug-induced hypersensitivity syndrome (DIH S), is an under-recognized and potentially life-threatening hypersensitivity reaction associated with a variety of med
Externí odkaz:
https://doaj.org/article/c31cd0437aa24d27b09a33b4ba3c1126
Autor:
Marina Ikić Matijašević, Petra Grubić Rotkvić, Zrinka Planinić, Lucija Ikić, Ines Zadro Kordić, Edvard Galić
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 4, p 134 (2023)
Systemic lupus erythematosus (SLE) myocarditis is presumed to be rare, but associated with adverse outcomes. If SLE diagnosis has not previously been established, its clinical presentation is often unspecific and difficult to recognize. Furthermore,
Externí odkaz:
https://doaj.org/article/7b53d0d226574bc2aaf009d4f455d2c1
Autor:
Marina Ikić Matijašević, Paula Kilić, Lucija Ikić, Iva Galić, Vlatka Brzović Šarić, Edvard Galić
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 3, p 2594 (2023)
Systemic lupus erythematosus (SLE) most commonly manifests as mild to moderate disease with severe manifestations such as diffuse alveolar hemorrhage, central nervous system vasculitis, macrophage activation syndrome (MAS) or retinal vasculitis (RV)
Externí odkaz:
https://doaj.org/article/5dfe297071fb45f2befd3dbdd9f1db52